All-cause Mortality Associated with TNF-α Inhibitors in Rheumatoid Arthritis: A Meta- Analysis of Randomized Controlled Trials Lucile Poiroux, MD, Yannick Allanore, MD, PhD, André Kahan, MD, PhD, Jérôme Avouac, MD, PhD The American Journal of Medicine Volume 128, Issue 12, Pages 1367-1373.e1 (December 2015) DOI: 10.1016/j.amjmed.2015.07.020 Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 1 Flow diagram of articles evaluated for inclusion and exclusion. RA = rheumatoid arthritis. The American Journal of Medicine 2015 128, 1367-1373.e1DOI: (10.1016/j.amjmed.2015.07.020) Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 2 Forest plot of trials comparing tumor necrosis factor-α inhibitors to comparators for the risk of all-cause mortality in patients with rheumatoid arthritis. Heterogeneity: Q = 7.87; df = 22, P = .99, I2 < 25%. The American Journal of Medicine 2015 128, 1367-1373.e1DOI: (10.1016/j.amjmed.2015.07.020) Copyright © 2015 Elsevier Inc. Terms and Conditions